Emerging Opportunities in Drug Delivery: Overcoming Barriers for New Modalities

Anand Subramony is Vice President of Novel Product Technologies at AstraZeneca. In this role, Anand heads the function from the CTO office and oversees efforts for creating patient centric products that rely on the principles of digital health, connected devices and other novel technologies including breathomics, sensors, wearables and novel diagnostics towards enabling improved patient outcome. Before his current role, Anand headed the drug delivery and device development at Medimmune and was Principal Fellow and Head of the Novel Delivery Technologies & Therapeutics within Development at the Novartis Institute for BioMedical Research where he established and managed a high performing cross functional team. In prior roles, Anand led the Materials Science function of the Biomedical Engineering group at Alza /J&J, and was Director of Materials Science & Drug delivery at Dr. Reddy’s Laboratories With his broad experience in pharma biotech, Anand brings in innovation and scientific rigor coupled with execution excellence and sense of urgency towards product development. Anand has over 25 refereed publications and several patents in the areas of drug delivery. Anand holds an MS in Materials Sc. Engineering from IIT Bombay and PhD from Purdue University